CD4+ TEM, CD4+ naïve T cells, and CD8+ cytotoxic T cells exhibited progressive enrichment from cancer-adjacent to primary tumors and metastatic tissues, suggesting their potential involvement in antitumor responses. The gene discussed is CD4; the disease is cancer.